Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SGX/H02 stock hub

SGX/H02 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SGX/H02is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

Singapore Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SGX/H02

In the news

Latest news · SGX/H02

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14

P25 18.2P50 25.4P75 35.6

Trailing P/E14.6

P25 15.6P50 22.4P75 35.2

ROE6.3

P25 -8.4P50 6.3P75 7.7

ROIC1.8

P25 -2.6P50 4P75 8.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SGX/H02 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

245

Groups with data

Currency

SGD

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Singapore
Country code	SG
Employees	595
Employees Change	66%
Employees Change Percent	12.48
Enterprise value	SGD 3.1B
Exchange	Singapore Exchange
Financial currency	SGD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	SG1D25001158
Last refreshed	2026-05-10
Market cap	SGD 3.9B
Price	SGD 17.49
Price currency	SGD
Rev Per Employee	386,499.16x
Sector	Healthcare
Sic	2834
Symbol	sgx/H02
Website	https://www.hawpar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.86%
EV Earnings	11.77x
EV/EBIT	43.46x
EV/EBITDA	39.93x
EV/FCF	56.81x
EV/Sales	13.59x
FCF yield	1.42%
Forward P/E	14.02x
P/B ratio	0.9x
P/E ratio	14.58x
P/S ratio	16.84x
PE Ratio10 Y	15.95x
PE Ratio3 Y	11.54x
PE Ratio5 Y	10.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.17%
EBITDA Margin	31.86%
FCF margin	23.92%
Gross margin	55.99%
Gross Profit	SGD 128.8M
Gross Profit Growth	-8.72%
Gross Profit Growth Q	-17.67%
Gross Profit Growth3 Y	-1.9%
Gross Profit Growth5 Y	3.27%
Net Income	SGD 265.5M
Net Income Growth	16.29%
Net Income Growth Q	14.16%
Net Income Growth Quarters	2%
Net Income Growth Years	4%
Net Income Growth3 Y	4.23%
Net Income Growth5 Y	8.66%
Pretax Margin	122.47%
Profit Margin	115.43%
Profit Per Employee	SGD 446,155
Profitable Years	25
ROA	0.96
Roa5y	0.87
ROCE	1.56
ROE	6.29
Roe5y	5.29
ROIC	1.78
Roic5y	1.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.06%
Cagr15y	12.15%
Cagr1y	56.15%
Cagr20y	9.55%
Cagr3y	30.31%
Cagr5y	11.92%
Div CAGR10	1.34%
Div CAGR3	10.06%
Div CAGR5	5.92%
EPS Growth	16.29
EPS Growth Q	14.16
EPS Growth Quarters	2
EPS Growth Years	4
EPS Growth3 Y	4.22
EPS Growth5 Y	8.68
FCF Growth	9.3%
FCF Growth Q	-18.76%
FCF Growth3 Y	-0.17%
FCF Growth5 Y	18.85%
OCF Growth	6.21%
OCF Growth Q	-18.7%
OCF Growth10 Y	8.6%
OCF Growth3 Y	-0.56%
OCF Growth5 Y	4.46%
Revenue Growth	-6.07x
Revenue Growth Q	-18.22x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.28x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SGD 0.05
Assets	SGD 4.4B
Cash	SGD 791.4M
Current Assets	SGD 854.9M
Current Liabilities	SGD 126M
Debt	SGD 44.7M
Debt EBITDA	SGD 0.61
Debt Equity	SGD 0.01
Debt FCF	SGD 0.81
Equity	SGD 4.3B
Interest Coverage	44.05
Liabilities	SGD 126.8M
Long Term Assets	SGD 3.6B
Long Term Liabilities	SGD 868,000
Net Cash	SGD 746.7M
Net Cash By Market Cap	SGD 19.29
Net Cash Growth	5.32%
Net Debt EBITDA	SGD -10.19
Net Debt Equity	SGD -0.17
Net Debt FCF	SGD -13.57
Tangible Book Value	SGD 4.3B
Tangible Book Value Per Share	SGD 19.33
WACC	5.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.79
Inventory Turnover	4.48
Net Working Capital	SGD -17.8M
Quick ratio	6.61
Working Capital	SGD 728.9M
Working Capital Turnover	SGD 0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-71.43%
Dividend Growth Years	3%
Dividend per share	SGD 0.4
Dividend Years	35
Dividend Yield	2.29%
Ex Div Date	2026-05-05
Last Dividend	SGD 0.2
Payout Frequency	Semi-Annual
Payout Ratio	33.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	212.27%
1Y total return	56.1%
200-day SMA	15.56
3Y total return	121.3%
50-day SMA	16.58
50-day SMA vs 200-day SMA	50over200
5Y total return	75.56%
All Time High	18.27
All Time High Change	-4.27%
All Time High Date	2026-04-16
All Time Low	0.93
All Time Low Change	1,786.12%
All Time Low Date	1998-09-02
ATR	0.32
Beta	0.18
Beta1y	0.31
Beta2y	0.35
Ch YTD	11.54
High	17.55
High52	18.27
High52 Date	2026-04-16
High52ch	-4.27%
Low	17.15
Low52	11.3
Low52 Date	2025-05-08
Low52ch	54.78%
Ma50ch	5.5%
Price vs 200-day SMA	12.43%
RSI	56.63
RSI Monthly	83.14
RSI Weekly	61.62
Sharpe ratio	2x
Sortino ratio	3.57
Total Return	2.29%
Tr YTD	12.85
Tr15y	458.5%
Tr1m	4.7%
Tr1w	2.28%
Tr3m	5.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SGD 67.1M
Operating Income Growth	1.97
Operating Income Growth Q	3.98
Operating Income Growth3 Y	-0.16
Operating Income Growth5 Y	5.8
Operating margin	29.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	138,207,130%
Net Borrowing	9,231,000
Shares Insiders	1.3%
Shares Institutions	29.04%
Shares Out	221,368,173
Shares Qo Q	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SGD 55M
Average Volume	314,295x
Bv Per Share	19.38
CAPEX	SGD -2.1M
Ch10y	100.6
Ch15y	212.8
Ch1m	3.49
Ch1w	1.1
Ch1y	52.09
Ch20y	193.7
Ch3m	4.48
Ch3y	84.11
Ch5y	38.48
Ch6m	12.91
Change	0.98%
Change From Open	0.98
Close	17.32
Days Gap	0
Depreciation Amortization	6,172,000
Dollar Volume	4,054,182
Earnings Date	2026-05-11
EBIT	SGD 67.1M
EBITDA	SGD 73.3M
EPS	SGD 1.2
F Score	5
FCF	SGD 55M
FCF EV Yield	1.76x
FCF Per Share	SGD 0.25
Financing CF	-302,415,000
Fiscal Year End	December
Founded	1,969
Goodwill	11,116,000
Graham Number	22.86969
Graham Upside	30.76
Income Tax	SGD 16.2M
Investing CF	292,832,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2013-05-21
Last Split Type	Forward
Lynch Fair Value	SGD 10.39
Lynch Upside	-40.61
Ma150	16.02
Ma150ch	9.16%
Ma20	17.47
Ma20ch	0.13%
Net CF	45,635,000
Next Earnings Date	2026-05-11
Open	17.32
P FCF Ratio	70.38
P OCF Ratio	67.77
Payment Date	2026-05-21
Position In Range	85
Ppne	94,876,000
Price Date	2026-05-08
Price EBITDA	SGD 52.85
Ptbv Ratio	0.9
Relative Volume	0.74x
Revenue	229,967,000x
Tax By Revenue	7.04x
Tax Rate	5.75%
Tr20y	520.16%
Tr6m	14.23%
Volume	231,800
Z Score	14.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SGX/H02 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$0.40 annual per share

Payout ratio

+33.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.9%

3 consecutive years of growth

Total shareholder yield

+2.3%

Next ex-dividend date: 2026-05-05

Performance

SGX/H02 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SGX/H02?

Insider, institutional, and short-interest positioning.

Institutional ownership

+29.0%

Share of float held by funds and institutions

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

SGX/H02 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

+12.4%

50/200-day relationship not available

Beta (5Y)

0.18

Less volatile than the market

Sharpe ratio

2.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SGX/H02

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sgx/H02 stock rating?

sgx/H02 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sgx/H02 analysis?

The full report lives at /stocks/sgx/H02/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sgx/H02?

The latest report frames sgx/H02 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sgx/H02 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.